MilliporeSigma has about 1,700 employees in Wisconsin at facilities in Milwaukee, Port Washington, Sheboygan and in the ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced a $76 million expansion of its ADC manufacturing ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced a $76 million ...

Expansion to create 170 jobs at Bioconjugation Center of Excellence in St. Louis, Missouri ST. LOUIS, October 29, 2024--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany (Merck KGaA), invested $76 million to expand its antibody drug conjugate (ADC) manufacturing capabilities ...

ST. LOUIS – MilliporeSigma ... enabling targeted therapies that minimize damage to healthy tissues.” Millipore Sigma looks to meet the global demand for ADCs. To accomplish this feat, they’re ...

All cell lines were maintained in RPMI growth medium (Life Technologies, Grand Island, NY) supplemented with 10% FBS (Millipore Sigma, St. Louis, MO), 100 U/mL penicillin and 100 ug/mL streptomycin ...

were purchased from Millipore Sigma (St. Louis, MO). Calmodulin binding peptide 1 (alphaII-spectrin peptide) was purchased from Genscript Biotech Corp. (Piscataway, NJ). Bacterial maltose binding ...